Fidelity Health Care Sector remains in the hands of a topnotch team that employs a sound and differentiated approach. The strategy, which includes two mutual funds, retains its High People and Above Average Process ratings.
Fidelity Advisor Health Care Fund - Class A FACDX
- NAV / 1-Day Return 62.55 / −1.74 %
- Total Assets 3.2B
-
Adj. Expense Ratio
0.930%
- Expense Ratio 0.930%
- Distribution Fee Level Low
- Share Class Type Front Load
- Category Health
- Investment Style Mid Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 52%
USD | NAV as of Jul 11, 2026 | 1-Day Return as of Jul 11, 2026, 4:51 AM GMT+0
Morningstar’s Analysis FACDX
Will FACDX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 38.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 8.14 | 236M | Healthcare |
Danaher Corp | 6.92 | 201M | Healthcare |
Johnson & Johnson | 4.89 | 142M | Healthcare |
Thermo Fisher Scientific Inc | 4.31 | 125M | Healthcare |
UnitedHealth Group Inc | 3.47 | 101M | Healthcare |
Alnylam Pharmaceuticals Inc | 2.44 | 71M | Healthcare |
Gilead Sciences Inc | 2.20 | 64M | Healthcare |
Ascendis Pharma AS | 2.19 | 64M | Healthcare |
Boston Scientific Corp | 2.16 | 63M | Healthcare |
AbbVie Inc | 2.10 | 61M | Healthcare |